Alopecia Areata is hair loss condition that affects approximately 1 in every 1,000 people at some point in their lives. Korean company AesMed may have developed a new form of treatment for Alopecia which uses ‘cytokines therapy’ to activate hair cells.
First of its kind
The company developed ‘the world’s first hair loss treatment by using growth factors’ in 2008, and today ‘Systemic Growth Factors – 57’, known as SGF-57, is used in university hospitals, cosmetic surgery clinics and dermatology departments across Korea.
No side effects?
SGF-57 is said to be effective in the treatment of hair loss, due to the blend of cytokine and growth factors of SCF, KGF, VEGF, IFG-I, rh-SOD and bFGF, which, when blended together, can help to regulate shedding whilst boosting growth. A representative for AesMed stated: “Cytokine is proven by many medical journals to differentiate and proliferate hair cells and control hair growth cycle. In more than 600,000 cases for performing alopecia treatment, SGF-57 has been proven to show its outstanding effectiveness and safety without any side effects until now.”
The treatment is allegedly free from side-effects, with the Journal of Dermatology and other industry publications offering the ingredient positive coverage.
AesMed: The company behind it all
AesMed is responsible for the design and development of medical devices and beauty products in South Korea and, since 2007, it has provided products to cosmetic surgery clinics and dermatology departments. The latest advanced technology has been used in the development of SGF-57, and it’s hoped that this new ingredient could be used to treat those affected by Alopecia.
About AlopeciaAlthough the precise cause is unknown, Alopecia Areata is classified as an auto-immune disorder. It is thought to be triggered by stressful or emotional events, leading to patchy hair loss which could even develop into total hair loss on the head or body (Alopecia Totalis and Alopecia Universalis respectively).
There are a few types of treatment for Alopecia Areata available at the moment, including minoxidil, an effective hair loss treatment that has been medically-proven to treat both male and female pattern hair loss, and which has also been seen to produce promising regrowth in many Alopecia Areata clients here at Belgravia, including Mr. H, pictured right. Unfortunately, treatment for Alopecia Totalis and Universalis is much more difficult, with a lower success rate.
If you are worried about Alopecia Areata or any other hair loss condition, you should contact a specialist as soon as possible, so that a bespoke hair loss treatment programme can be tailored to suit your individual needs.
The Belgravia Centre
The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.